Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
61.37%
↑ 13% vs avg
Percentile
P86
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
54.24%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 61.37% |
| Q3 2025 | 18.20% |
| Q2 2025 | 25.65% |
| Q1 2025 | 19.64% |
| Q4 2024 | 930.81% |
| Q3 2024 | -143.27% |
| Q2 2024 | 32.41% |
| Q1 2024 | -8.57% |
| Q4 2023 | -74.84% |
| Q3 2023 | 549.30% |
| Q2 2023 | 11.98% |
| Q1 2023 | 62.83% |
| Q4 2022 | -118.61% |
| Q3 2022 | 881.35% |
| Q2 2022 | 78.45% |
| Q1 2022 | -92.56% |
| Q4 2021 | 33.00% |
| Q3 2021 | 26.47% |
| Q2 2021 | 35.45% |
| Q1 2021 | -45.90% |
| Q4 2020 | -20.16% |
| Q3 2020 | -17.46% |
| Q2 2020 | 8.73% |
| Q1 2020 | -22.37% |
| Q4 2019 | 11.92% |
| Q3 2019 | 27.33% |
| Q2 2019 | 36.93% |
| Q1 2019 | -104.77% |
| Q4 2018 | -47.58% |
| Q3 2018 | -18.15% |
| Q2 2018 | -20.64% |
| Q1 2018 | 35.65% |
| Q4 2017 | -113.13% |
| Q3 2017 | -7.17% |
| Q2 2017 | -79.69% |
| Q1 2017 | 0.00% |